# Comparative Clinical Study of Drug-coating Balloon Strategy and Drug-eluting Stent Strategy

Study · id `cardio:ct-nct04842838` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04842838](<https://clinicaltrials.gov/study/NCT04842838>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04842838

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1000 participants.

## Technical summary

Registry record NCT04842838. Randomized; single masking; primary purpose treatment. Start 2021-06-30 (anticipated); primary completion 2023-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1000 participants (planned count; ClinicalTrials.gov record NCT04842838, source copy `cardio:ctgov-nct04842838-2021-04-13`, retrieved 2026-10-26)
- Planned start: 2021-06-30 (anticipated) (ClinicalTrials.gov record NCT04842838, source copy `cardio:ctgov-nct04842838-2021-04-13`, retrieved 2026-10-26)
- Primary completion: 2023-06-30 (anticipated) (ClinicalTrials.gov record NCT04842838, source copy `cardio:ctgov-nct04842838-2021-04-13`, retrieved 2026-10-26)
- Completion: 2025-06-30 (anticipated) (ClinicalTrials.gov record NCT04842838, source copy `cardio:ctgov-nct04842838-2021-04-13`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04842838, source copy `cardio:ctgov-nct04842838-2021-04-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04842838-2021-04-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparative Clinical Study of Drug-coating Balloon Strategy and Drug-eluting Stent Strategy
- Acronym: Kissing-DCB
- Condition: Coronary Artery Disease
- Intervention (Device): paclitaxel DCB
- Intervention (Device): DES
- Lead sponsor: Peking University Third Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Peking University Third Hospital (`cardio:org-peking-university-third-hospital`)

## Provenance

Content hash: 06eeb7c394d1054de36f544a382635d22e35da59ca40853bd7de334a7bc7c77a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
